La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (Istex)

Index « ISSN » - entrée « Synapse »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Sust. Dev. < Synapse < TECH  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]
Ident.Authors (with country if any)Title
000306 (2012) Terence K. Y. Lai [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada]Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia
000418 (2011) L. Macgillivray [Canada] ; K. B. Reynolds [Canada] ; M. Sickand [Canada] ; P. I. Rosebush [Canada] ; M. F. Mazurek [Canada]Inhibition of the serotonin transporter induces microglial activation and downregulation of dopaminergic neurons in the substantia nigra
000474 (2011) Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada]Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia
000628 (2010) André R. Troiano [Canada] ; Michael Schulzer [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Vesna Sossi [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter PET in normal aging: Dopamine transporter decline and its possible role in preservation of motor function
000769 (2009) Stéphane Potvin [Canada] ; Sylvain Grignon [Canada] ; Serge Marchand [Canada]Human evidence of a supra‐spinal modulating role of dopamine on pain perception
000778 (2009) Philip Seeman [Canada] ; Hong-Chang Guan [Canada]Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors
000779 (2009) Philip Seeman [Canada] ; Hong-Chang Guan [Canada]Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor
000795 (2009) Philip Seeman [Canada]Dopamine D2High receptors measured ex vivo are elevated in amphetamine‐sensitized animals
000872 (2008) Annie Larouche [Canada] ; Patrick Berube [Canada] ; Philippe Sarret [Canada] ; Sylvain Grignon [Canada]Subacute H2O2, but not poly(IC), upregulates dopamine D2 receptors in retinoic acid differentiated SH‐SY5Y neuroblastoma
000884 (2008) Joohyung Lee [Canada, Australie] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi Visanji [Canada] ; Jonathan M. Brotchie [Canada]Receptor‐activity modifying protein 1 expression is increased in the striatum following repeated L‐DOPA administration in a 6‐hydroxydopamine lesioned rat model of Parkinson's disease
000899 (2008) Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Fréderic Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Mehdi Dridi [Canada] ; Nancy Belanger [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L‐dopa‐induced dyskinesias in MPTP parkinsonian monkeys
000908 (2008) Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine]Memantine agonist action at dopamine D2High receptors
000925 (2008) Yuhua Jiang [Canada, République populaire de Chine] ; Lin Pei [Canada] ; Shupeng Li [Canada] ; Min Wang [Canada] ; Fang Liu [Canada]Extracellular dopamine induces the oxidative toxicity of SH‐SY5Y cells
000936 (2008) Philip Seeman [Canada]Dopamine D2High receptors on intact cells
000937 (2008) Philip Seeman [Canada]Dopamine D2High receptors moderately elevated by sertindole
000938 (2008) Philip Seeman [Canada]Dopamine D2High receptors moderately elevated by bifeprunox and aripiprazole
000A56 (2007) Philip Seeman [Canada] ; Patrick N. Mccormick [Canada] ; Shitij Kapur [Canada]Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO
000A92 (2007) Philip Seeman [Canada]Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors
000B47 (2006) Philip Seeman [Canada] ; Johannes Schwarz [Allemagne] ; Jiang-Fan Chen [États-Unis] ; Henry Szechtman [Canada] ; Melissa Perreault [Canada] ; G. Stanley Mcknight [États-Unis] ; John C. Roder [Canada] ; Rémi Quirion [Canada] ; Patricia Boksa [Canada] ; Lalit K. Srivastava [Canada] ; Kazuhiko Yanai [Japon] ; David Weinshenker [États-Unis] ; Tomiki Sumiyoshi [Japon]Psychosis pathways converge via D2High dopamine receptors
000B49 (2006) Marc Morissette [Canada] ; Mehdi Dridi [Canada] ; Frédéric Calon [Canada] ; Abdallah Hadj Tahar [Canada] ; Leonard T. Meltzer [États-Unis] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada]Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: Effect on adenosine A2A receptors
000C71 (2005) Claudia L. R. Gonzalez [Canada] ; Omar A. Gharbawie [Canada] ; Ian Q. Whishaw [Canada] ; Bryan Kolb [Canada]Nicotine stimulates dendritic arborization in motor cortex and improves concurrent motor skill but impairs subsequent motor learning

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/ISSN.i -k "Synapse" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/ISSN.i  \
                -Sk "Synapse" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    ISSN.i
   |clé=    Synapse
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022